+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Proton Pump Inhibitor"

From
Dyspepsia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dyspepsia Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 566 Pages
  • Global
From
Duodenal Ulcer Treatment - Global Strategic Business Report - Product Thumbnail Image

Duodenal Ulcer Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 380 Pages
  • Global
From
From
Antacids - Global Strategic Business Report - Product Thumbnail Image

Antacids - Global Strategic Business Report

  • Report
  • November 2025
  • 486 Pages
  • Global
From
Gastrointestinal Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gastrointestinal Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 193 Pages
  • Global
From
Peptic Ulcer Drugs - Global Strategic Business Report - Product Thumbnail Image

Peptic Ulcer Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 196 Pages
  • Global
From
From
Geriatric Medicines - Global Strategic Business Report - Product Thumbnail Image

Geriatric Medicines - Global Strategic Business Report

  • Report
  • November 2025
  • 304 Pages
  • Global
From
Gastroesophageal Reflux Disease Therapeutics Market Report 2025 - Product Thumbnail Image

Gastroesophageal Reflux Disease Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Gastric Antisecretory Drug Market Report 2025 - Product Thumbnail Image

Gastric Antisecretory Drug Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
H2 Antagonists Global Market Report 2025 - Product Thumbnail Image

H2 Antagonists Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Gastric Ulcers Market Report 2025 - Product Thumbnail Image

Gastric Ulcers Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Erosive Esophagitis - Pipeline Insight, 2025 - Product Thumbnail Image

Erosive Esophagitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Eosinophilic Esophagitis - Pipeline Insight, 2025 - Product Thumbnail Image

Eosinophilic Esophagitis - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Gastritis - Pipeline Insight, 2025 - Product Thumbnail Image

Gastritis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Peptic Ulcer - Pipeline Insight, 2025 - Product Thumbnail Image

Peptic Ulcer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastric Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Ulcers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Proton Pump Inhibitors (PPIs) are a class of drugs used to treat Gastrointestinal (GI) disorders. They work by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux, heartburn, and other GI conditions. PPIs are available in both prescription and over-the-counter forms, and are often used in combination with other medications to treat more severe GI conditions. Common side effects of PPIs include headache, nausea, and diarrhea. PPIs are among the most widely prescribed drugs in the world, and are used to treat a variety of GI conditions. They are often used as a first-line treatment for acid reflux and other GI disorders, and are also used to prevent and treat ulcers. Some of the major companies in the PPI market include AstraZeneca, Pfizer, Takeda, and GlaxoSmithKline. These companies produce a variety of PPIs, including omeprazole, lansoprazole, and pantoprazole. Show Less Read more